# The Human Medicines Regulations 2012, Paragraph 13

Extent: E+W+S+N.I.

For medicinal products included in the list referred to in Article 23 of Regulation (EC) No 726/2004 in the case of products for sale or supply in Northern Ireland, or the list referred to in regulation 202A, in the case of products for sale or supply in Great Britain, the symbol and statement: “▼ This medicinal product is subject to additional ... monitoring”.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/27/paragraph/13 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-27/paragraph-13
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.